LINC00667 and breast carcinoma: The downregulation of gene expression is characteristic for LINC00667 in the papillary subtype of bladder cancer (Figure S4C), LINC00667 in basal-like and HER2 breast cancer (Figure S4D), and LINC00667 in colorectal adenocarcinoma with high microsatellite instability (Figure S4E).